In fact, several reports have shown that when epithelial tumor cells switch from expressing E-CAD to expressing N-CAD (cadherin switch phenomenon), they acquire the ability to activate Fibroblast Growth Factor Receptor (FGFR) pathways. Here, CAD is linked to neoplasm.